Financhill
Back

Karuna Therapeutics 10K Form

Buy
62

KRTX
Karuna Therapeutics

Last Price:
318.95
Seasonality Move:
-6.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KRTX News And Ratings

See the #1 stock for the next 7 days that we like better than KRTX

KRTX Financial Statistics

Sales & Book Value

Annual Sales: $10.64M
Cash Flow: $-110.63M
Price / Cash Flow: 0
Annual Sales: $35.06
Price / Book: 9.17

Profitability

EPS (TTM): -10.93000
Net Income (TTM): $-396.07M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Karuna Therapeutics Earnings Forecast

Key Karuna Therapeutics Financial Ratios

  • The Research & Development expenses have been 2,108.18% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of KRTX is -2,597.88% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 1 years.

Karuna Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: KRTX
CUSIP: 48576A
Website: karunatx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

KRTX Technical Analysis vs Fundamental Analysis

Buy
62
Karuna Therapeutics (KRTX) is a Buy

Is Karuna Therapeutics a Buy or a Sell?